Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Evaluation of patients with abnormal newborn screens showing
elevations of C4 to aid in the differential diagnosis of SCAD
deficiency and IBD deficiency
An isolated elevation of iso-butyrylcarnitine (C4) in newborn screening
blood spots is related to a diagnosis of either short-chain acyl-CoA
dehydrogenase (SCAD) deficiency or isobutyryl-CoA dehydrogenase
(IBD) deficiency. Follow-up confirmatory and diagnostic testing is
necessary to differentiate the 2 clinical entities. The American College
of Medical Genetics (ACMG) newborn screening work group published
diagnostic algorithms for the follow-up of infants who had a positive
newborn screening result-see
http://www.acmg.net/resources/policies/ACT/Visio-C4_(4-19-06).pdf.
Evaluation of C4 excretion in urine is part of the recommended diagnostic
workup, as it is useful for differentiating between SCAD deficiency and IBD
deficiency.
See "Newborn Screening Follow-up for Isolated C4 Acylcarnitine
Elevations" in Special Instructions for additional information.
<3.00 millimoles/mole creatinine
Almost all patients with IBD deficiency excrete an abnormal amount
of C4 in their urine. Some, but not all, affected individuals also
over excrete isobutyrylglycine. Conversely, patients with SCAD
deficiency can have a normal excretion of C4.
See "Newborn Screening Follow-up for Isolated C4 Acylcarnitine
Elevations" in Special Instructions for additional information.
The results of urine acylcarnitines are not informative when
the patient is receiving L-carnitine supplements.
Oglesbee D, Vockley J, Ensenauer RE, et al: Ten cases of isobutyryl-
CoA dehydrogenase (IBDH) deficiency detected by newborn
screening. JIMD 2005;28(Suppl 1):13